CSOAR

Founded in 2012 and based in Xi’an, China, CSOAR operates in the High-tech Industrial Development Zone. The company has built independent laboratories and production workshops, supported by a research team consisting of experts in material science and chemistry. Over the years, the company has developed and commercialized multiple products in the optoelectronic materials field while also expanding into liquid crystal and pharmaceutical intermediate applications. The company designs, synthesizes, and produces materials required for OLED, liquid crystal, and pharmaceutical applications.

Its portfolio includes OLED display materials, liquid crystal intermediates, and pharmaceutical intermediates, which are used in electronics, display technologies, and chemical industries. CSOAR also provides technical services and customized solutions for material development to meet client-specific requirements. The company generates revenue from the development, production, and sales of optoelectronic and chemical materials, supplying industries such as display technology, electronics, and pharmaceuticals. In August 2025, CSOAR closed Series A funding from new investors Shaanxi Investment Fund Management, Wenrun Investment, Lianhu Investment and Tianhong Investment.